June 14th 2023

The deal, valued at more than $2 billion dollars, will see Quell Therapeutics develop various T-regulatory cell therapies for AstraZeneca.

June 12th 2023

World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.

June 8th 2023

The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.

June 8th 2023

The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.

June 8th 2023

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

May 30th 2023

Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.

May 30th 2023

The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.

May 24th 2023

Ironwood Pharmaceuticals’ acquisition of VectivBio grants it the rights to apraglutide, a glucagon-like peptide being evaluated for gastrointestinal diseases.

May 17th 2023

Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.

May 16th 2023

In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.